Universal Health Services, Inc. (NYSE:UHS) Q2 2021 Results Conference Call July 27, 2021 9:00 AM ET Company Participants Steve Filton - Chief Financial Officer Marc Miller - President Conference Call Participants Kevin Fischbeck - Bank of America Marco Criscuolo - Nephron Research Ralph Giacobbe - Citi Pito Chickering - Deutsche Bank Jamie Perse - Goldman Sachs Frank Morgan - RBC Capital Markets A.J. Rice - Crédit Suisse Operator Good day and thank you for standing by. Welcome to the Universal Health Servic ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-10765 UNIVERSAL HEALTH SERVICES, INC. (Exact name of registrant as specified in its charter) DELAWARE 23-2077891 (State or other j ...

Universal Health Services, Inc. (NYSE:UHS) Q1 2021 Earnings Conference Call April 27, 2021 9:00 AM ET Company Participants Steve Filton - Executive Vice President & Chief Financial Officer Marc Miller - President Conference Call Participants Perry Wong - Wolfe Research Kevin Fischbeck - Bank of America Ralph Giacobbe - Citi Jamie Perse - Goldman Sachs Pito Chickering - Deutsche Bank A.J. Rice - Credit Suisse John Ransom - Raymond James Operator Good day and thank you for standing by. Welcome to the First Qu ...

Universal Health Services, Inc. (NYSE:UHS) Q4 2020 Results Earnings Conference Call February 26, 2021 9:00 AM ET Company Participants Steve Filton - Executive Vice President & Chief Financial Officer Marc Miller - President Conference Call Participants Andrew Mok - Barclays Kevin Fischbeck - Bank of America Ralph Giacobbe - Citibank A.J. Rice - Credit Suisse Pito Chickering - Deutsche Bank Justin Lake - Wolfe Research Josh Raskin - Nephron Jamie Perse - Goldman Sachs Whit Mayo - UBS Operator Ladies and gent ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (MARK ONE) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 1-10765 UNIVERSAL HEALTH SERVICES, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-10765 UNIVERSAL HEALTH SERVICES, INC. (Exact name of registrant as specified in its charter) DELAWARE 23-2077891 (State or oth ...

Universal Health Services, Inc. (NYSE:UHS) Q3 2020 Earnings Conference Call October 30, 2020 10:00 AM ET Company Participants Steve Filton - Executive Vice President & Chief Financial Officer Alan Miller - Chairman & Chief Executive Officer Marc Miller - President Conference Call Participants Andrew Mok - Barclays Matthew Borsch - BMO Capital Markets Kevin Fischbeck - Bank of America A.J. Rice - Credit Suisse Sarah James - Piper Sandler Pito Chickering - Deutsche Bank Ralph Giacobbe - Citi Josh Raskin - Nep ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-10765 UNIVERSAL HEALTH SERVICES, INC. (Exact name of registrant as specified in its charter) DELAWARE 23-2077891 (State or other ju ...

Financial Data and Key Metrics Changes - The company reported net income attributable to UHS per diluted share of $2.95 for Q2 2020, with adjusted net income of $2.93 after accounting for certain items [5] - Approximately $320 million was received from governmental stimulus programs, with $218 million recorded as net revenues in Q2, including $157 million from acute care facilities and $61 million from behavioral health facilities [5][6] - The company has close to $1.4 billion in aggregate available borrowing capacity and nearly $600 million in short-term cash investments as of June 30, 2020 [13] Business Line Data and Key Metrics Changes - Acute care facilities saw a rebound in patient day metrics beginning in late April, with volumes recovering sharply after restrictions on elective surgeries were lifted [7] - The behavioral health segment experienced a similar recovery, with patient days returning to near pre-COVID levels by mid-June, despite challenges from reduced referrals [10] - ER visits have been the slowest to recover, remaining approximately 25% below pre-COVID levels [18] Market Data and Key Metrics Changes - The second wave of COVID cases in late June did not lead to the same magnitude of non-COVID case declines as experienced in the first wave [8] - The company noted that most of its facilities are located in COVID hotspots, affecting overall volume trends [22] Company Strategy and Development Direction - The company has implemented cost reduction initiatives across all expense categories, including a reduction in planned capital spending and a suspension of share repurchase and dividend programs [11][12] - Management acknowledged the potential material impact of COVID-19 on future operations and has refrained from providing earnings guidance for the remainder of 2020 [14] Management Comments on Operating Environment and Future Outlook - Management expressed concern over the ongoing COVID-19 crisis and its impact on patient volumes and financial results, emphasizing the need for careful monitoring of the situation [14] - The company is optimistic about the underlying demand for behavioral services, suggesting that the stress of the current environment may lead to increased demand for care [20][60] Other Important Information - The company has faced challenges in obtaining timely COVID test results, which remains a concern [9] - Management highlighted the importance of maintaining a safe environment for both patients and employees during the crisis [11] Q&A Session Summary Question: Can you provide numbers around acute and behavioral volume trends exiting June? - Management indicated that both acute and behavioral patient days were averaging around 95% of pre-COVID levels in mid-June, but saw a decline in July due to the second wave of COVID [17] Question: What is driving the July declining volume? - Management noted that the majority of facilities are located in COVID hotspots, leading to broad-based trends in volume declines [22] Question: Can you discuss margin loss and revenue for the quarter? - Management explained that margins improved in Q2 compared to Q1, but fixed costs make it challenging to reduce expenses at the same rate as revenue declines [25] Question: What actions have been taken for expense management? - Management detailed broad expense reductions across categories, including labor adjustments and a reduction in premium labor costs [28] Question: How is behavioral demand performing geographically? - Management observed robust demand for behavioral services across various diagnoses, despite challenges from closed schools and reduced ER referrals [35][60] Question: What is the impact of telehealth on behavioral health strategy? - Management highlighted that telehealth has provided an alternative access point for patients, enhancing the ability to reach those hesitant to enter traditional care settings [50] Question: Can you disaggregate the Medicare accelerated payments and deferred government stimulus? - Management clarified that $375 million is from Medicare accelerated payments, while approximately $100 million are stimulus funds not yet recognized in income [52] Question: What is the status of behavioral business initiatives? - Management indicated that many initiatives were put on hold due to COVID, but there is hope to resume discussions with payers in the future [56][57]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-10765 UNIVERSAL HEALTH SERVICES, INC. (Exact name of registrant as specified in its charter) DELAWARE 23-2077891 (State or other j ...